84 results
8-K
EX-99.2
LGVN
Longeveron Inc - Ordinary Shares
18 Apr 24
Longeveron Announces Exercise of Warrants for $6.2 Million Gross Proceeds
4:30pm
,” or “anticipates” or the negative thereof or comparable terminology, or by discussion of strategy or goals or other future events, circumstances, or effects
8-K
EX-99.1
LGVN
Longeveron Inc - Ordinary Shares
18 Apr 24
Longeveron Announces Exercise of Warrants for $6.2 Million Gross Proceeds
4:30pm
,” “potential,” “estimates,” “preliminary,” or “anticipates” or the negative thereof or comparable terminology, or by discussion of strategy or goals or other
8-K
EX-99.1
LGVN
Longeveron Inc - Ordinary Shares
11 Apr 24
Longeveron Announces Pricing of $5.25 Million Public Offering
5:10pm
or goals or other future events, circumstances, or effects and include, but are not limited to, statements regarding the completion of the offering
8-K
EX-99.2
LGVN
Longeveron Inc - Ordinary Shares
11 Apr 24
Longeveron Announces Pricing of $5.25 Million Public Offering
5:10pm
or comparable terminology, or by discussion of strategy or goals or other future events, circumstances, or effects and include, but are not limited to, statements
424B4
LGVN
Longeveron Inc - Ordinary Shares
10 Apr 24
Prospectus supplement with pricing info
7:48am
will not receive a refund in the event that we do not sell an amount of securities sufficient to pursue our business goals described in this prospectus … of securities sufficient to pursue the business goals outlined in this prospectus.
The placement agent has agreed to use its reasonable best efforts
FWP
6877x6 uz9o3w
8 Apr 24
Free writing prospectus
8:45am
8-K
EX-99.1
x1x4 hiesk6
19 Mar 24
Longeveron Announces 1-for-10 Reverse Stock Split
4:01pm
8-K
EX-99.1
2uom2 2ju
22 Dec 23
UPDATE -- Longeveron Announces $2.36 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
8:44am
8-K
EX-99.1
nd6d0x
13 Oct 23
Longeveron Announces $4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
8:00am
8-K
EX-99.2
o2075l
5 Oct 23
Longeveron Announces Positive Top-Line Results for Lomecel-BTM in its CLEAR MIND Phase 2a Clinical Trial in the Treatment of Mild Alzheimer’s Disease
7:36am
8-K
EX-99.1
aune snbxjq
5 Oct 23
Longeveron Announces Positive Top-Line Results for Lomecel-BTM in its CLEAR MIND Phase 2a Clinical Trial in the Treatment of Mild Alzheimer’s Disease
7:36am